Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 QIAGEN, BD Settle Patent Infringement Suit - Medical Product Outsourcing
OEM News

QIAGEN, BD Settle Patent Infringement Suit

BD will receive a one-time, lump-sum payment of $53 million.

QIAGEN and BD have reached a settlement in the patent infringement lawsuit related to QIAGEN’s NeuMoDx 96 and NeuMoDx 288 clinical PCR systems that QIAGEN acquired from NeuMoDx Inc. in 2020.
 
Under terms of the agreement, all pending patent and non-patent claims have been resolved between BD and QIAGEN and the co-defendants who were former officers of NeuMoDx in the lawsuit in the U.S. District Court for the District of Delaware. BD will receive a one-time, lump-sum payment of $53 million. The settlement includes general releases of all parties with no admissions of wrongdoing.
 
This agreement does not affect QIAGEN’s outlook for net sales and adjusted earnings per share (EPS) for the fourth quarter and full-year 2021.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters